- Home
- CRIS vs NRT Comparison
CRIS vs NRT Comparison
Compare CRIS & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- NRT
- Stock Information
- Founded
- CRIS 2000
- NRT 1975
- Country
- CRIS United States
- NRT United States
- Employees
- CRIS N/A
- NRT N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- NRT Oil & Gas Production
- Sector
- CRIS Health Care
- NRT Energy
- Exchange
- CRIS Nasdaq
- NRT Nasdaq
- Market Cap
- CRIS 32.8M
- NRT 44.0M
- IPO Year
- CRIS 2000
- NRT N/A
- Fundamental
- Price
- CRIS $2.84
- NRT $4.28
- Analyst Decision
- CRIS Strong Buy
- NRT
- Analyst Count
- CRIS 3
- NRT 0
- Target Price
- CRIS $23.00
- NRT N/A
- AVG Volume (30 Days)
- CRIS 28.2K
- NRT 26.2K
- Earning Date
- CRIS 05-06-2025
- NRT 02-28-2025
- Dividend Yield
- CRIS N/A
- NRT 11.14%
- EPS Growth
- CRIS N/A
- NRT N/A
- EPS
- CRIS N/A
- NRT 0.56
- Revenue
- CRIS $10,259,000.00
- NRT $5,942,748.00
- Revenue This Year
- CRIS N/A
- NRT N/A
- Revenue Next Year
- CRIS N/A
- NRT N/A
- P/E Ratio
- CRIS N/A
- NRT $7.60
- Revenue Growth
- CRIS 0.44
- NRT N/A
- 52 Week Low
- CRIS $2.57
- NRT $3.88
- 52 Week High
- CRIS $17.49
- NRT $8.62
- Technical
- Relative Strength Index (RSI)
- CRIS 41.65
- NRT 41.99
- Support Level
- CRIS $2.57
- NRT $4.16
- Resistance Level
- CRIS $3.15
- NRT $4.46
- Average True Range (ATR)
- CRIS 0.17
- NRT 0.20
- MACD
- CRIS -0.02
- NRT -0.03
- Stochastic Oscillator
- CRIS 44.26
- NRT 24.00
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.